TECHNOVAX INC

Tarrytown, NY · Biotech · Private

Virus-like particle (VLP) based respiratory syncytial virus (RSV) vaccine displaying F protein antigens

Claim this profile

Follows are private to you and power your alerts

Updated Oct 23, 2026 · technovax.com

Sector: Biotech
Headquarters: Tarrytown, NY
Total capital: $6.8M

Federal grants: $4.1M; 5 awards · 2016–2020; Rank in peer group#469 of 514
Private capital raised: None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts: $2.7M; 3 awards · Health and Human S, Defense; Rank in Biotech#118 of 4373
Granted patents: 8; 10 pending · first 2016; Rank in peer group#40 of 514

Capital timeline

Latest events

Aug 2020Federal grantHealth and Human S · Phase I · Production and Testing of VLP-based RSV Vaccine$300K
Aug 2020Federal grantHealth and Human S · Phase I · Production and Testing of VLP-based RSV Vaccine$300K
Sep 2019Federal contractDefense · Army 15.1 SBIR Topic Dha Funded SBIR 2ND Phase II Medical R&d Contract For Proposal #H2-0475, Titled: "next-generation Adenovirus Vaccine" Erms 19151002$2.6M
Aug 2019Federal grantHealth and Human S · Phase II · Universal VLP-Based Flu Vaccine:Broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza A virus subtypes.$734K
Aug 2018Federal grantHealth and Human S · Phase II · Universal VLP-Based Flu Vaccine:Broadly protective (universal) virus-like particle (VLP) based influenza vaccine that can neutralize a broad spectrum of influenza A virus subtypes.$747K
Sep 2016Federal grantDefense · Phase II · Next-Generation Adenovirus Vaccine$2M
Sep 2015Federal contractDefense · Igf::ot::igf Army Phase One SBIR Proposal# A151-051-0493$150K

Show 1 earlier federal award

Jan 2011Federal contractHealth and Human S · Purchase Of Virus-like Particles$5K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 514 peers

Line = median

Biotech · Molecule

Federal grantsBelow median
Granted patents#40 · top 8%
Linked publications#85 · top 17%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 8 granted of 18

Oct 12, 2023PendingSEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS [SARS-CoV-2]-VIRUS-LIKE PARTICLE [VLP] VACCINE: COMPOSITIONS, DELIVERY STRATEGIES, METHODS AND USESUSPTOApplication 18041883
Dec 20, 2022GrantedUniversal Virus-like Particle (vlp) Influenza VaccinesUSPTOUS 11,529,410
Jul 19, 2022GrantedFlavivirus And Alphavirus Virus-like Particles (vlps)USPTOUS 11,389,522

Show all 18 patent records

SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS [SARS-CoV-2]-VIRUS-LIKE PARTICLE [VLP] VACCINE: COMPOSITIONS, DELIVERY STRATEGIES, METHODS AND USESOct 12, 2023 · Application 18041883Pending
Universal Virus-like Particle (vlp) Influenza VaccinesDec 20, 2022 · US 11,529,410Granted
Flavivirus And Alphavirus Virus-like Particles (vlps)Jul 19, 2022 · US 11,389,522Granted
Human Respiratory Syncytial Virus (hrsv) Virus-like Particles (vlps) Based VaccineMay 10, 2022 · US 11,324,816Granted
Flavivirus And Alphavirus Virus-like Particles (vlps)Oct 13, 2020 · US 10,799,575Granted
Universal Virus-like Particle (vlp) Influenza VaccinesJun 30, 2020 · US 10,695,418Granted
Inhalable Vaccine Compositions And MethodsDec 25, 2018 · US 10,159,644Granted
Universal Virus-like Particle (vlp) Influenza VaccinesSep 25, 2018 · US 10,080,796Granted
Influenza Virus-like Particle (vlp) CompositionsJul 12, 2016 · US 9,387,241Granted
Polyvalent Influenza Virus-like Particle (vlp) CompositionsOct 22, 2015 · Application 14733642Pending
Severe Acute Respiratory Syndrome Coronavirus [SARS-COV-2]-VIRUS-LIKE Particle [vlp] Vaccine: Compositions, Delivery Strategies, Methods And UsesApplication PCTUS2021046353Pending
Inhalable Vaccine Compositions And MethodsApplication PCTUS2013066969Pending
Universal Virus-like Particle (vlp) Influenza VaccinesApplication PCTUS2011000300Pending
Respiratory Syncytial Virus (rsv) Virus-like Particles (vlps)Application PCTUS2010052307Pending
Polyvalent Influenza Virus-like Particle (vlp) CompositionsApplication PCTUS2007010405Pending
Flavivirus And Alphavirus Virus-like Particles (vlps)Application PCTUS2016039011Pending
Influenza Virus-like Particle (vlp) CompositionsApplication PCTUS2007010402Pending
Human Respiratory Syncytial Virus (hrsv) Virus-like Particles (vlps) Based VaccineApplication PCTUS2016049226Pending

Recent research by its founders

Structure of Human adenovirus 7 virus-like particles, a platform for developing nanotherapeutics and studying capsid assembly20260 cites
The structure of the Human Adenovirus 7 virus-like particles reveals that pentons and core-genome promote hexon-pIIIa interactions during capsid maturation20250 cites
Fibrodisplasia osificante progresiva en un felino, a propósito de un caso clínico20240 cites

EPIBONE, INC.Similar federal contract value in Biotech · $2.8M in contracts
AGILE SCIENCES, INC.Similar federal contract value in Biotech · $2.7M in contracts
Amplyx Pharmaceuticals, Inc.Similar federal contract value in Biotech · $2.7M in contracts
OMICSCRAFT LLCSimilar federal contract value in Biotech · $2.7M in contracts
RADIOPHARMACEUTICAL IMAGING AND DOSIMETRY, LLCSimilar federal contract value in Biotech · $2.6M in contracts
Senti Biosciences Holdings, Inc.Similar federal contract value in Biotech · $2.6M in contracts

Regulatory activity · Biotech

Sector-level, not company-level

07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through Oct 23, 2026. SBIR and STTR awards through Oct 21, 2026.